| 000 | 00904 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250511215247.0 | ||
| 264 | 0 | _c19910327 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0041-1132 | ||
| 024 | 7 |
_a10.1046/j.1537-2995.1991.31291142958.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEshleman, J R | |
| 245 | 0 | 0 |
_aThe development of selective plasmapheresis as a means for specific therapeutic intervention. _h[electronic resource] |
| 260 |
_bTransfusion _cFeb 1991 |
||
| 300 |
_a96-8 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aRheumatoid Factor _xblood |
| 700 | 1 | _aSilberstein, L E | |
| 773 | 0 |
_tTransfusion _gvol. 31 _gno. 2 _gp. 96-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1537-2995.1991.31291142958.x _zAvailable from publisher's website |
| 999 |
_c2002673 _d2002673 |
||